Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

14M Genomics

14M Genomics?uq=U5Zpp9ZJ
Out of Business LATEST DEAL TYPE

Provider of clinical genomics services designed to help in cancer diagnostics. The company's state-of-the-art sequencing and analytical tools generate linked genomic and clinical datasets to provide a reference, enabling patients to access diagnostic and prognostic stratification, along with treatment options from oncologists.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • Wellcome Trust Genome Campus
  • Hinxton
  • Cambridge CB10 1SA
  • England

+44 01223 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 14M Genomics’s full profile, request a free trial.

14M Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 29-Feb-2016 000.00 Completed Out of Business
1. Early Stage VC 18-Dec-2014 000.00 000.00 Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

14M Genomics Executive Team (7)

Name Title Board
Alan Schafer Ph.D Chief Executive Officer
Philip Beer Ph.D Director of Medical Genomics
Michael Stratton Ph.D Co-Founder
Ultan McDermott Ph.D Co-Founder
Peter Campbell Ph.D Co-Founder

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

14M Genomics Board Members (3)

Name Representing Role Since Contact
David Chiswell Ph.D Self Board Member 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »